<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Heissam K</submitter><funding>U.S. Food and Drug Administration</funding><pagination>e0241441</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7657519</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(11)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The gastrointestinal environment in which drug products need to disintegrate before the drug can dissolve and be absorbed has not been studied in detail due to limitations, especially invasiveness of existing techniques. Minimal in vivo data is available on undisturbed gastrointestinal motility to improve relevance of predictive dissolution models and in silico tools such as physiologically-based pharmacokinetic models. Recent advances in magnetic resonance imaging methods could provide novel data and insights that can be used as a reference to validate and, if necessary, optimize these models. The conventional method for measuring gastrointestinal motility is via a manometric technique involving intubation. Nevertheless, it is feasible to measure gastrointestinal motilit</pubmed_abstract><journal>PloS one</journal><pubmed_title>Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomitant perfused manometry in healthy participants.</pubmed_title><pmcid>PMC7657519</pmcid><funding_grant_id>HHSF223201510157C</funding_grant_id><pubmed_authors>Heissam K</pubmed_authors><pubmed_authors>Hebbard G</pubmed_authors><pubmed_authors>Abrehart N</pubmed_authors><pubmed_authors>Brasseur JG</pubmed_authors><pubmed_authors>Glover PM</pubmed_authors><pubmed_authors>Dickens J</pubmed_authors><pubmed_authors>Gowland PA</pubmed_authors><pubmed_authors>Marciani L</pubmed_authors><pubmed_authors>Hoad CL</pubmed_authors><pubmed_authors>Shedden K</pubmed_authors><pubmed_authors>Menys A</pubmed_authors><pubmed_authors>Spiller RC</pubmed_authors><pubmed_authors>Baker J</pubmed_authors><pubmed_authors>Corsetti M</pubmed_authors><pubmed_authors>Amidon GE</pubmed_authors><pubmed_authors>Wright J</pubmed_authors><pubmed_authors>Hasler WL</pubmed_authors><pubmed_authors>Murray K</pubmed_authors><pubmed_authors>Hens B</pubmed_authors><pubmed_authors>Amidon GL</pubmed_authors><pubmed_authors>Mudie DM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomitant perfused manometry in healthy participants.</name><description>&lt;h4>Objective&lt;/h4>The gastrointestinal environment in which drug products need to disintegrate before the drug can dissolve and be absorbed has not been studied in detail due to limitations, especially invasiveness of existing techniques. Minimal in vivo data is available on undisturbed gastrointestinal motility to improve relevance of predictive dissolution models and in silico tools such as physiologically-based pharmacokinetic models. Recent advances in magnetic resonance imaging methods could provide novel data and insights that can be used as a reference to validate and, if necessary, optimize these models. The conventional method for measuring gastrointestinal motility is via a manometric technique involving intubation. Nevertheless, it is feasible to measure gastrointestinal motilit</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2026-05-04T23:47:12.118Z</modification><creation>2020-11-22T09:41:51Z</creation></dates><accession>S-EPMC7657519</accession><cross_references><pubmed>33175860</pubmed><doi>10.1371/journal.pone.0241441</doi></cross_references></HashMap>